Sign in
4

Changes in Ownership

OCULAR THERAPEUTIX, INC Filed Acc 0001104659-24-011201

Chief Business Officer sold 5,910 shares at $4.86 ($28,723)

  • Chief Business Officer acquired 39,980 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

White Christopher G · Chief Business Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-02-03 Grant or award : show line 1 in the form +39,980 129,599 D
2024-02-05 Sale : show line 2 in the form +5,910 $4.86 $28,723 123,689 D
Open-market sales · 5,910 sh · avg $4.86 · $28,723

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-02-03 Grant or award : show line 3 in the form Stock Option (Right to Buy) +120,000 120,000 D
Loading xslF345X05/tm245295-5_4seq1.xml…